Medlive Technology Co Ltd
Company Profile
Business description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians who make procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan’s leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Contact
No. 1 Baijialou Chaoyang North Road
E1 Red Manor International Bonded Innovation Park
Chaoyang District
Beijing
CHNSector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2025
Employees
746
Stocks News & Analysis
stocks
Ask the analyst: Can this big Covid loser scale its former heights?
stocks
The fight for Insignia continues
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.40 | 31.30 | 0.36% |
| CAC 40 | 7,964.85 | 72.24 | 0.92% |
| DAX 40 | 21,497.14 | 85.61 | 0.40% |
| Dow JONES (US) | 44,565.07 | 408.34 | 0.92% |
| FTSE 100 | 8,536.79 | 28.41 | -0.33% |
| HKSE | 20,066.19 | 365.63 | 1.86% |
| NASDAQ | 20,053.68 | 44.34 | 0.22% |
| Nikkei 225 | 39,931.98 | 26.89 | -0.07% |
| NZX 50 Index | 13,024.70 | 35.38 | -0.27% |
| S&P 500 | 6,118.71 | 32.34 | 0.53% |
| S&P/ASX 200 | 8,408.90 | 30.20 | 0.36% |
| SSE Composite Index | 3,252.63 | 22.46 | 0.70% |